CLINICAL_TRIALS
research
· 2026-04-06
Clinical Trial Update: CHIP/CCUS Natural History Protocol
Summary
An NHLBI-supported protocol to study the natural history of clonal hematopoiesis of indeterminate potential and clonal cytopenia of undetermined significance; t…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Clonal Hematopoiesis of Indeterminate Potential, Clonal Cytopenia of Undetermined Significance | Status: RECRUITING